Evidence at the Bedside

Dr. Taylor // Dr. Griffin
  • 1.0 (1)
  • Medicine
  • Updated Daily

Evidence at the Bedside is a medical education podcast focused on clinically relevant, evidence-based discussions that translate guidelines and research into practical bedside decision-making. Disclaimer: For educational use only. Contains AI-generated content. Not medical advice; no physician-patient relationship established. Always cross-reference with primary literature and guidelines. Consult a licensed professional for diagnosis and treatment. Use at your own risk. This study aid is not a substitute for professional clinical judgment or medical consultation.

  1. 2d ago

    Rheumatology 7: MCTD (Rapid Review)

    Fire up this Rapid Review sprint on Mixed and Undifferentiated Connective Tissue Diseases from the Evidence at the Bedside team. We use rapid-fire active recall to cement the exact autoantibody associations, disease complications, and prognostic timelines you need to know for the boards. #ABIM #InternalMedicine #ITEPrep #RapidReview #Rheumatology #MCTD #BoardReview #EvidenceAtTheBedside

  2. 3d ago

    Mixed Connective Tissue Disease

    Welcome to another high-yield episode of Evidence at the Bedside: ABIM Edition. This week, we navigate the gray areas of rheumatology by unpacking overlap syndromes. We break down the diagnostic criteria, autoantibody profiles, and clinical trajectories of Mixed Connective Tissue Disease (MCTD) and Undifferentiated Connective Tissue Disease (UCTD) to ensure you are prepared for the wards and the boards. #ABIM #InternalMedicine #Rheumatology #MCTD #UCTD #Autoimmune #MedEd #BoardReview #EvidenceAtTheBedside

  3. 4d ago

    Rheumatology 6: Systemic Sclerosis (Rapid Review)

    Fire up this Rapid Review sprint on Systemic Sclerosis from the Evidence at the Bedside team. We use rapid-fire active recall to cement the exact autoantibody associations, medication rules, and high-yield systemic complications you need to know for the boards. Rapid Review Highlights: Antibody Matching: Actively recalling that anti-Scl-70 strongly correlates with diffuse disease and interstitial lung disease, whereas anti-centromere antibodies strongly correlate with limited disease and pulmonary arterial hypertension. Scleroderma Renal Crisis: Cementing the critical board rule that ACE inhibitors (like captopril) must be initiated and titrated to control blood pressure in scleroderma renal crisis, even if the serum creatinine is actively rising. Glucocorticoid Danger: Rapidly identifying that the use of high-dose glucocorticoids (greater than 15 mg/day) is a major risk factor for precipitating scleroderma renal crisis. ILD Management: Remembering that mycophenolate mofetil is the preferred first-line agent for the treatment of systemic sclerosis-associated interstitial lung disease. Gastrointestinal Clues: Recognizing that gastric antral vascular ectasia (GAVE), also known as "watermelon stomach," is a classic cause of GI bleeding in patients with diffuse cutaneous systemic sclerosis. Test your diagnostic knowledge, identify your blind spots, and crush the rheumatology section of your exams! #ABIM #InternalMedicine #ITEPrep #RapidReview #Rheumatology #Scleroderma #BoardReview #EvidenceAtTheBedside

  4. 5d ago

    Systemic Sclerosis

    Welcome back to Evidence at the Bedside: ABIM Edition. This week, we explore the complex multiorgan landscape of Systemic Sclerosis (SSc). We unpack the critical differences between limited and diffuse disease, the autoantibody profiles that predict internal organ involvement, and the life-saving interventions required for scleroderma renal crisis. #ABIM #InternalMedicine #Rheumatology #SystemicSclerosis #Scleroderma #MedEd #BoardReview #EvidenceAtTheBedside

  5. Sep 10

    Rheumatology 5: Crystal Arthropathies and Gout (Rapid Review)

    Short on time before your ITE or ABIM exam? Fire up this Rapid Review sprint on Crystal Arthropathies from the Evidence at the Bedside team. We use rapid-fire active recall to cement the exact diagnostic criteria, crystal morphologies, and medication safety rules you need to know for the boards. #ABIM #InternalMedicine #ITEPrep #RapidReview #Rheumatology #Gout #BoardReview #EvidenceAtTheBedside

  6. Sep 9

    Crystal Arthropathies and Gout

    Welcome back to Evidence at the Bedside: ABIM Edition. This week, we are diving into the painful and highly testable world of Crystal Arthropathies. We break down the pathophysiology, diagnostic gold standards, and evolving management guidelines for Gout, Calcium Pyrophosphate Deposition (CPPD), and Basic Calcium Phosphate (BCP) deposition to ensure you are ready for the wards and the boards. #ABIM #InternalMedicine #Rheumatology #Gout #Pseudogout #CrystalArthropathy #MedEd #BoardReview #EvidenceAtTheBedside

  7. Sep 8

    Rheumatology 4: Sjogren Disease (Rapid Review)

    Fire up this Rapid Review sprint on Sjögren Disease from the Evidence at the Bedside team. We use rapid-fire active recall to cement the exact diagnostic thresholds, medication contraindications, and high-yield systemic complications you need to know for the boards. #ABIM #InternalMedicine #ITEPrep #RapidReview #Rheumatology #Sjogrens #BoardReview #EvidenceAtTheBedside

  8. Sep 7

    Sjogren Disease

    Welcome to another high-yield episode of Evidence at the Bedside: ABIM Edition. This week, we explore the systemic complexities of Sjögren Disease. We go beyond the classic sicca symptoms to cover the critical extraglandular manifestations, diagnostic criteria, and management strategies you need to master for the wards and your certification exams. #ABIM #InternalMedicine #Rheumatology #SjogrenDisease #Autoimmune #MedEd #BoardReview #EvidenceAtTheBedside

See All (135)

About

Evidence at the Bedside is a medical education podcast focused on clinically relevant, evidence-based discussions that translate guidelines and research into practical bedside decision-making. Disclaimer: For educational use only. Contains AI-generated content. Not medical advice; no physician-patient relationship established. Always cross-reference with primary literature and guidelines. Consult a licensed professional for diagnosis and treatment. Use at your own risk. This study aid is not a substitute for professional clinical judgment or medical consultation.

Information

  • Creator
    Dr. Taylor // Dr. Griffin
  • Years Active
    2026
  • Episodes
    135
  • Rating
    Clean
  • Copyright
    © Dr. Taylor // Dr. Griffin
  • Show Website
    Evidence at the Bedside